TY - JOUR
T1 - Elevated Plasma Homocysteine and Low Vitamin B-6 Status in Nonsupplementing Older Women with Rheumatoid Arthritis
AU - Woolf, Kathleen
AU - Manore, Melinda M.
N1 - Funding Information:
Financial support for this research came from the Association for Gerontology in Higher Education and the Arizona State University Graduate Research Program.
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2008/3
Y1 - 2008/3
N2 - Objective: The purpose of this study was to determine if nonsupplementing older women (aged ≥55 years) with rheumatoid arthritis had higher plasma homocysteine and lower B-vitamin status compared to healthy controls. Elevated plasma homocysteine, a risk factor for cardiovascular disease, may help explain why individuals with rheumatoid arthritis have an increased risk of cardiovascular disease. Methods: Older, free-living women were classified as rheumatoid arthritis (n=18) or healthy control (n=33). Participants were not using B-vitamin supplements. Fasting blood samples were measured for pyridoxal 5′phosphate (PLP) (the metabolically active coenzyme form of vitamin B-6), folate, red blood cell folate, vitamin B-12, transcobalamin II, homocysteine, C-reactive protein, and lipid concentrations. Participants completed 7-day weighed food records, the Stanford Health Assessment Questionnaire (HAQ), and a visual analog pain scale. Results: PLP concentrations were lower in the rheumatoid arthritis vs healthy control participants (4.93±3.85 vs 11.35±7.11 ng/mL [20±16 vs 46±29 nmol/L]; P<0.01) whereas plasma homocysteine was higher in the rheumatoid arthritis group (1.63±0.74 vs 1.15±0.38 mg/L [12.1±5.5 vs 8.5±2.8 μmol/L]; P=0.02). Red blood cell folate concentrations were lower in the rheumatoid arthritis vs healthy control participants [414±141 vs 525±172 ng/mL [938±320 vs 1,190±390 nmol/L]; P=0.02). No significant differences were found for plasma folate, vitamin B-12, and transcobalamin II. An inverse correlation was found between PLP concentrations and the HAQ disability index (r=-0.37; P<0.01). A positive correlation was found between homocysteine concentrations and the HAQ disability index (r=0.36; P=0.01). Total cholesterol and low-density lipoprotein cholesterol levels were lower in the rheumatoid arthritis group (cholesterol 191±43 vs 218±33 mg/dL [4.95±1.11 vs 5.65±0.85 mmol/L]; P=0.02; low-density lipoprotein cholesterol 110±36 vs 137±29 mg/dL [2.85±0.93 vs 3.55±0.75 mmol/L]; P<0.01). No significant differences were seen between groups for protein (g/day), fat (g/day), cholesterol (mg/day), folate (μg/day), vitamin B-12 (μg/day), and vitamin B-6 (mg/day) dietary intakes. Conclusions: Poor vitamin B-6 status and elevated plasma homocysteine concentrations were seen in older women with rheumatoid arthritis compared to healthy controls and may contribute to their increased risk of cardiovascular disease.
AB - Objective: The purpose of this study was to determine if nonsupplementing older women (aged ≥55 years) with rheumatoid arthritis had higher plasma homocysteine and lower B-vitamin status compared to healthy controls. Elevated plasma homocysteine, a risk factor for cardiovascular disease, may help explain why individuals with rheumatoid arthritis have an increased risk of cardiovascular disease. Methods: Older, free-living women were classified as rheumatoid arthritis (n=18) or healthy control (n=33). Participants were not using B-vitamin supplements. Fasting blood samples were measured for pyridoxal 5′phosphate (PLP) (the metabolically active coenzyme form of vitamin B-6), folate, red blood cell folate, vitamin B-12, transcobalamin II, homocysteine, C-reactive protein, and lipid concentrations. Participants completed 7-day weighed food records, the Stanford Health Assessment Questionnaire (HAQ), and a visual analog pain scale. Results: PLP concentrations were lower in the rheumatoid arthritis vs healthy control participants (4.93±3.85 vs 11.35±7.11 ng/mL [20±16 vs 46±29 nmol/L]; P<0.01) whereas plasma homocysteine was higher in the rheumatoid arthritis group (1.63±0.74 vs 1.15±0.38 mg/L [12.1±5.5 vs 8.5±2.8 μmol/L]; P=0.02). Red blood cell folate concentrations were lower in the rheumatoid arthritis vs healthy control participants [414±141 vs 525±172 ng/mL [938±320 vs 1,190±390 nmol/L]; P=0.02). No significant differences were found for plasma folate, vitamin B-12, and transcobalamin II. An inverse correlation was found between PLP concentrations and the HAQ disability index (r=-0.37; P<0.01). A positive correlation was found between homocysteine concentrations and the HAQ disability index (r=0.36; P=0.01). Total cholesterol and low-density lipoprotein cholesterol levels were lower in the rheumatoid arthritis group (cholesterol 191±43 vs 218±33 mg/dL [4.95±1.11 vs 5.65±0.85 mmol/L]; P=0.02; low-density lipoprotein cholesterol 110±36 vs 137±29 mg/dL [2.85±0.93 vs 3.55±0.75 mmol/L]; P<0.01). No significant differences were seen between groups for protein (g/day), fat (g/day), cholesterol (mg/day), folate (μg/day), vitamin B-12 (μg/day), and vitamin B-6 (mg/day) dietary intakes. Conclusions: Poor vitamin B-6 status and elevated plasma homocysteine concentrations were seen in older women with rheumatoid arthritis compared to healthy controls and may contribute to their increased risk of cardiovascular disease.
UR - http://www.scopus.com/inward/record.url?scp=39649105655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39649105655&partnerID=8YFLogxK
U2 - 10.1016/j.jada.2007.12.001
DO - 10.1016/j.jada.2007.12.001
M3 - Article
C2 - 18313425
AN - SCOPUS:39649105655
SN - 0002-8223
VL - 108
SP - 443
EP - 453
JO - Journal of the American Dietetic Association
JF - Journal of the American Dietetic Association
IS - 3
ER -